Literature DB >> 17035326

Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection.

Rui Soares1, Russell Foxall, Adriana Albuquerque, Catarina Cortesão, Miguel Garcia, Rui M M Victorino, Ana E Sousa.   

Abstract

CCR5 expression determines susceptibility to infection, cell tropism, and the rate of human immunodeficiency virus type 1 (HIV-1) disease progression. CCR5 is also considered the major HIV-2 coreceptor in vivo, in spite of broad coreceptor use in vitro. Here we report a significantly increased proportion of memory-effector CD4 T cells expressing CCR5 in HIV-2-infected patients correlating with CD4 depletion. Moreover, HIV-2 proviral DNA was essentially restricted to memory-effector CD4, suggesting that this is the main target for HIV-2. Similar levels of proviral DNA were found in the two infection categories. Thus, the reduced viremia and slow rate of CD4 decline that characterize HIV-2 infection seem to be unrelated to coreceptor availability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035326      PMCID: PMC1676275          DOI: 10.1128/JVI.01557-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Pathways for internalization and recycling of the chemokine receptor CCR5.

Authors:  Anja Mueller; Eamonn Kelly; Philip G Strange
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

Authors:  S J Popper; A D Sarr; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Preferential and persistent depletion of CCR5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection.

Authors:  R Krzysiek; A Rudent; L Bouchet-Delbos; A Foussat; C Boutillon; A Portier; D Ingrand; D Sereni; P Galanaud; L Grangeot-Keros; D Emilie
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

4.  Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes.

Authors:  A E Sousa; A F Chaves; A Loureiro; R M Victorino
Journal:  J Infect Dis       Date:  2001-07-31       Impact factor: 5.226

5.  CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; O Avinens; M C Picot; J Clot; J F Eliaou; P Corbeau
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

6.  In vitro correlates of HIV-2-mediated HIV-1 protection.

Authors:  E G Kokkotou; J L Sankale; I Mani; A Gueye-Ndiaye; D Schwartz; M E Essex; S Mboup; P J Kanki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.

Authors:  B Schramm; M L Penn; E H Palacios; R M Grant; F Kirchhoff; M A Goldsmith
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.

Authors:  S Andersson; H Norrgren; Z da Silva; A Biague; S Bamba; S Kwok; C Christopherson; G Biberfeld; J Albert
Journal:  Arch Intern Med       Date:  2000-11-27

9.  CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates.

Authors:  Andreas Mörner; Asa Björndal; Ann-Charlotte Leandersson; Jan Albert; Ewa Björling; Marianne Jansson
Journal:  AIDS Res Hum Retroviruses       Date:  2002-02-10       Impact factor: 2.205

10.  Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration.

Authors:  Sundararajan Venkatesan; Ana Petrovic; Donald I Van Ryk; Massimo Locati; Drew Weissman; Philip M Murphy
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

View more
  13 in total

1.  Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients.

Authors:  Rui S Soares; Rita Tendeiro; Russell B Foxall; António P Baptista; Rita Cavaleiro; Perpétua Gomes; Ricardo Camacho; Emília Valadas; Manuela Doroana; Margarida Lucas; Francisco Antunes; Rui M M Victorino; Ana E Sousa
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

2.  Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes.

Authors:  Helena Nunes-Cabaço; Paula Matoso; Russell B Foxall; Rita Tendeiro; Ana R Pires; Tânia Carvalho; Ana I Pinheiro; Rui S Soares; Ana E Sousa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

3.  Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.

Authors:  David Gautier; Stéphanie Beq; Catarina S Cortesão; Ana E Sousa; Rémi Cheynier
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

4.  Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1.

Authors:  Russell B Foxall; Catarina S Cortesão; Adriana S Albuquerque; Rui S Soares; Rui M M Victorino; Ana E Sousa
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

5.  Quantification of HIV-2 DNA in Whole Blood.

Authors:  Zsófia Szojka; Sara Karlson; Marianne Jansson; Patrik Medstrand
Journal:  Bio Protoc       Date:  2019-10-20

6.  Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.

Authors:  Helena Barroso; Pedro Borrego; Inês Bártolo; José Maria Marcelino; Carlos Família; Alexandre Quintas; Nuno Taveira
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

7.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

8.  Generalized immune activation as a direct result of activated CD4+ T cell killing.

Authors:  Rute Marques; Adam Williams; Urszula Eksmond; Andy Wullaert; Nigel Killeen; Manolis Pasparakis; Dimitris Kioussis; George Kassiotis
Journal:  J Biol       Date:  2009

9.  In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4.

Authors:  Edwin A Higuita; Fabián A Jaimes; Maria T Rugeles; Carlos J Montoya
Journal:  AIDS Res Ther       Date:  2013-05-01       Impact factor: 2.250

10.  The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.

Authors:  Pedro Borrego; José Maria Marcelino; Cheila Rocha; Manuela Doroana; Francisco Antunes; Fernando Maltez; Perpétua Gomes; Carlos Novo; Helena Barroso; Nuno Taveira
Journal:  Retrovirology       Date:  2008-09-08       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.